Milwaukee, WI-based Dr. Comfort released results in July of a study showing people with type 2 diabetes who wear therapeutic shoes lower their likelihood of developing foot ulcers and undergoing lower limb amputations.
The retrospective claims database study reviewed records of more than 26,000 patients who wore therapeutic footwear over a three-year period: one year before the first therapeutic shoe claim and up to two years after starting therapeutic shoe wear.
The cohort’s medical claims for foot ulcers decreased by 2% from baseline to one year and by 12% at two years, while amputations claims decreased by 29% at one year and 18% at two years compared with baseline.
Vista, CA-based DJO Global, which owns Dr. Comfort, supported the study.
Researchers, who include investigators from Rush University Medical Center in Chicago, DJO Global, and Truven Health Analytics in Ann Arbor, MI, will present additional results at the Pedorthic Footcare Association Annual Symposium & Exhibition, scheduled for October 24-26 in Orlando, FL.